IHH Healthcare Berhad Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
IHH Healthcare Berhad wird ein jährliches Gewinn- und Umsatzwachstum von 0.7% bzw. 5.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich sinken um 4.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 6.9% betragen.
Wichtige Informationen
0.7%
Wachstumsrate der Gewinne
-4.6%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 2.3% |
| Wachstumsrate der Einnahmen | 5.6% |
| Zukünftige Eigenkapitalrendite | 6.9% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 06 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Recent updates
Is IHH Healthcare Berhad (KLSE:IHH) Trading At A 38% Discount?
Nov 04
IHH Healthcare Berhad's (KLSE:IHH) Returns On Capital Are Heading Higher
Oct 20IHH Healthcare Berhad (KLSE:IHH) Seems To Use Debt Quite Sensibly
Sep 19IHH Healthcare Berhad (KLSE:IHH) Has Announced A Dividend Of MYR0.045
Sep 03Some Shareholders Feeling Restless Over IHH Healthcare Berhad's (KLSE:IHH) P/E Ratio
Aug 29Returns On Capital Are Showing Encouraging Signs At IHH Healthcare Berhad (KLSE:IHH)
Jul 16IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 29% Below Their Intrinsic Value Estimate
Jun 24Some Investors May Be Willing To Look Past IHH Healthcare Berhad's (KLSE:IHH) Soft Earnings
Jun 05Do IHH Healthcare Berhad's (KLSE:IHH) Earnings Warrant Your Attention?
May 28Unpleasant Surprises Could Be In Store For IHH Healthcare Berhad's (KLSE:IHH) Shares
May 13IHH Healthcare Berhad (KLSE:IHH) Seems To Use Debt Quite Sensibly
Mar 17Does IHH Healthcare Berhad (KLSE:IHH) Deserve A Spot On Your Watchlist?
Feb 25Investors Will Want IHH Healthcare Berhad's (KLSE:IHH) Growth In ROCE To Persist
Feb 09Estimating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)
Jan 25Subdued Growth No Barrier To IHH Healthcare Berhad's (KLSE:IHH) Price
Jan 09Is IHH Healthcare Berhad (KLSE:IHH) A Risky Investment?
Nov 27There's Been No Shortage Of Growth Recently For IHH Healthcare Berhad's (KLSE:IHH) Returns On Capital
Oct 25Is Now The Time To Put IHH Healthcare Berhad (KLSE:IHH) On Your Watchlist?
Oct 10Estimating The Fair Value Of IHH Healthcare Berhad (KLSE:IHH)
Sep 14Returns At IHH Healthcare Berhad (KLSE:IHH) Are On The Way Up
Jul 24Here's Why IHH Healthcare Berhad (KLSE:IHH) Has Caught The Eye Of Investors
Jun 16IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 22% Above Their Intrinsic Value Estimate
May 18IHH Healthcare Berhad (KLSE:IHH) Has A Pretty Healthy Balance Sheet
Apr 26IHH Healthcare Berhad (KLSE:IHH) Has Announced That It Will Be Increasing Its Dividend To MYR0.07
Mar 16Returns At IHH Healthcare Berhad (KLSE:IHH) Are On The Way Up
Mar 10Calculating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)
Feb 17These 4 Measures Indicate That IHH Healthcare Berhad (KLSE:IHH) Is Using Debt Reasonably Well
Jan 25IHH Healthcare Berhad (KLSE:IHH) Shareholders Will Want The ROCE Trajectory To Continue
Nov 23A Look At The Fair Value Of IHH Healthcare Berhad (KLSE:IHH)
Nov 04IHH Healthcare Berhad (KLSE:IHH) Has A Rock Solid Balance Sheet
Oct 18Here's Why IHH Healthcare Berhad (KLSE:IHH) Has Caught The Eye Of Investors
Oct 02IHH Healthcare Berhad (KLSE:IHH) Is Experiencing Growth In Returns On Capital
Aug 23Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 26,618 | 2,361 | 3,489 | 5,152 | 17 |
| 12/31/2025 | 24,550 | 2,092 | 2,571 | 4,640 | 20 |
| 12/31/2024 | 22,926 | 1,959 | 2,262 | 5,025 | 20 |
| 6/30/2024 | 23,167 | 2,651 | 1,510 | 4,193 | N/A |
| 3/31/2024 | 21,748 | 2,329 | 1,581 | 3,930 | N/A |
| 12/31/2023 | 20,935 | 2,952 | 1,816 | 3,759 | N/A |
| 9/30/2023 | 20,316 | 2,415 | 1,870 | 3,747 | N/A |
| 6/30/2023 | 19,071 | 2,128 | 1,847 | 3,432 | N/A |
| 3/31/2023 | 18,968 | 2,415 | 2,194 | 3,864 | N/A |
| 12/31/2022 | 17,989 | 1,496 | 1,951 | 3,668 | N/A |
| 9/30/2022 | 17,967 | 1,736 | 2,273 | 3,945 | N/A |
| 6/30/2022 | 17,736 | 2,019 | 2,336 | 3,775 | N/A |
| 3/31/2022 | 17,435 | 1,891 | 2,272 | 3,429 | N/A |
| 12/31/2021 | 17,218 | 1,774 | 2,477 | 3,532 | N/A |
| 9/30/2021 | 16,427 | 1,740 | 2,249 | 3,169 | N/A |
| 6/30/2021 | 15,500 | 1,500 | 2,295 | 3,168 | N/A |
| 3/31/2021 | 13,795 | 895 | 1,750 | 2,549 | N/A |
| 12/31/2020 | 13,405 | 199 | 1,553 | 2,445 | N/A |
| 9/30/2020 | 13,475 | -180 | 1,418 | 2,402 | N/A |
| 6/30/2020 | 13,745 | -253 | 1,110 | 2,093 | N/A |
| 3/31/2020 | 14,825 | 53 | 1,353 | 2,488 | N/A |
| 12/31/2019 | 14,912 | 463 | 1,369 | 2,447 | N/A |
| 9/30/2019 | 14,242 | 932 | 1,307 | 2,265 | N/A |
| 6/30/2019 | 13,294 | 592 | 948 | 1,995 | N/A |
| 3/31/2019 | 12,309 | 573 | 781 | 1,857 | N/A |
| 12/31/2018 | 11,521 | 542 | 803 | 1,864 | N/A |
| 9/30/2018 | 11,241 | 134 | 836 | 2,065 | N/A |
| 6/30/2018 | 11,201 | 326 | 1,210 | 2,295 | N/A |
| 3/31/2018 | 11,313 | 498 | N/A | 2,258 | N/A |
| 12/31/2017 | 11,143 | 931 | N/A | 2,261 | N/A |
| 9/30/2017 | 10,889 | 810 | N/A | 2,186 | N/A |
| 6/30/2017 | 10,530 | 917 | N/A | 1,984 | N/A |
| 3/31/2017 | 10,231 | 847 | N/A | 1,983 | N/A |
| 12/31/2016 | 10,022 | 612 | N/A | 1,934 | N/A |
| 9/30/2016 | 9,685 | 1,071 | N/A | 1,875 | N/A |
| 6/30/2016 | 9,308 | 1,016 | N/A | 1,884 | N/A |
| 3/31/2016 | 8,928 | 998 | N/A | 1,917 | N/A |
| 12/31/2015 | 8,455 | 934 | N/A | 1,986 | N/A |
| 9/30/2015 | 8,098 | 757 | N/A | 1,836 | N/A |
| 6/30/2015 | 7,818 | 786 | N/A | 1,858 | N/A |
| 3/31/2015 | 7,589 | 767 | N/A | 1,771 | N/A |
| 12/31/2014 | 7,344 | 754 | N/A | 1,631 | N/A |
| 9/30/2014 | 7,187 | 745 | N/A | 1,656 | N/A |
| 6/30/2014 | 7,075 | 715 | N/A | 1,537 | N/A |
| 3/31/2014 | 6,889 | 663 | N/A | 1,382 | N/A |
| 12/31/2013 | 6,756 | 631 | N/A | 1,338 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: IHHDas prognostizierte Gewinnwachstum (0.7% pro Jahr) liegt unter der Sparquote (3.6%).
Ertrag vs. Markt: IHHDie Erträge des Unternehmens (0.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt MY (10.3% pro Jahr).
Hohe Wachstumserträge: IHHDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: IHHDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt MY (6.1% pro Jahr).
Hohe Wachstumseinnahmen: IHHDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: IHHDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (6.9%).